Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer

Stopped Negative sorafenib results from ESCAPE trial and safety concerns of regimen

Conditions

• Non-Small Cell Lung Cancer

Interventions

• DRUG: Cisplatin
• DRUG: Etoposide
• PROCEDURE: Radiotherapy
• DRUG: Sorafenib

Sponsor

Nasser Hanna, M.D.

Collaborators

• [object Object]
• [object Object]
• [object Object]